Latest Articles

Publication Date
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post

FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post

Published: Nov. 14, 2025, 3:26 p.m.
‘I was rushed to hospital with sepsis after years of crippling pain – doctors even feared it could be cancer before discovering the real cause’ - needtoknow.co.uk

‘I was rushed to hospital with sepsis after years of crippling pain – doctors even feared it could be cancer before discovering the real cause’ needtoknow.co.uk

Published: Nov. 14, 2025, 9:26 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International

Published: Nov. 14, 2025, 4:25 a.m.
Woman's Bloating & Indigestion Turned Out To Be Ovarian Cancer - SurvivorNet

Woman's Bloating & Indigestion Turned Out To Be Ovarian Cancer SurvivorNet

Published: Nov. 14, 2025, 2:15 a.m.
Endometriosis During Peri-Menopause and Post-Menopause: A Review of the Literature.

Endometriosis is traditionally regarded as a condition predominantly affecting women of reproductive age, often associated with infertility and cyclical pelvic pain. As a result, a significant body of research and …

Published: Nov. 14, 2025, midnight
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative

Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative

Published: Nov. 13, 2025, 9:25 p.m.
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal

Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal

Published: Nov. 13, 2025, 1:03 p.m.
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech

Published: Nov. 13, 2025, 9 a.m.
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer - CancerNetwork

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork

Published: Nov. 12, 2025, 7:12 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!